Assembly Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Assembly Biosciences

09/08/2023 22:52

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 29 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of 32 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Assembly Biosciences Inc shares had fallen by 6.1% this
quarter and lost 16.9% so far this year.
    * The company reported a quarterly loss of $16.9 million.
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $2.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:52 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.29          -0.32          Missed
 Mar. 31 2023      -0.35          -0.37          Missed
 Dec. 31 2022      -0.45          -0.46          Missed
 Sep. 30 2022      -0.47          -0.48          Missed